LOGIN
Autonomous Blood Drawing Technology - Vitestro
We transform patient care with autonomous blood drawing technology
Autonomous Medical Robot - Vitestro
Autonomous Blood Drawing Technology | Medical Robot | Vitestro

Introducing Aletta®: The New Standard for Blood Drawing

Vitestro is pioneering the introduction of autonomous robotic phlebotomy in European hospitals. With billions of blood draws performed annually worldwide, precise and efficient diagnostic blood collection is a critical component of patient care. As healthcare systems face increasing shortages of well trained and highly skilled phlebotomists, there is a clear and urgent need for an innovative solution that automates the blood drawing process, ensuring consistent quality, operational efficiency, and continuity of care.

About Aletta® 

Aletta®, the world's first Autonomous Robotic Phlebotomy Device™ (ARPD™), is transforming blood collection with fully automated, AI-driven robotic precision. Using state-of-the-art Doppler ultrasound-guided imaging combined with robotic needle insertion, Aletta® optimizes accuracy and safety for all patients. The entire procedure—from tourniquet application to bandaging—is performed autonomously, minimizing variability and enhancing procedural reliability.
REQUEST MORE INFORMATION

Redefining patient experience

Designed for accessibility and ease of use, Aletta® prioritizes a seamless, intuitive and patient-friendly experience. With its human-centered design, Aletta can be used under supervision across all patient populations, ensuring a comfortable and confident blood draw experience while reducing the burden on healthcare professionals.
Autonomous Blood Drawing Technology | Medical Robot | Vitestro

Clinical development with R&D partners

Vitestro performs its clinical development activities together with leading European hospitals and laboratories.
  • 'More than 2000 patients participated in clinical trials, multiple hospitals participated '
    - Toon Overbeeke, CEO Vitestro
  • 'By introducing automated blood drawing, high quality, as well as capacity, is guaranteed in our laboratories.’
    - Anja Leyte, Director OLVG Laboratories
  • 'Vitestro's technology helps improving sample standardization and solving staffing shortages at our blood drawing department. Patients are also very positive.'
    - Anja Leyte, Director OVLG Laboratories
  • 'Automated blood drawing will play a key role in the future of laboratory medicine. 
    I can't wait to see the first devices working in our labs.'
    - François Verheijen, Clinical Chemist, Result Laboratorium, NL
  • 'It is great to see, during clinical testing, how the device can make a difference for patients.'
    - Luuk Giesen, Medical Officer Vitestro

Collaborating with leading hospitals

Vitestro is thrilled to receive extensive support from leading hospitals and clinical laboratories across Europe. Together we will realize a future where our autonomous device has become the standard, transforming patient care for millions of people.
Autonomous Blood Drawing Technology | Medical Robot | Vitestro

Patient First

The company goals is to provide a high level of patient safety and to reduce anxiety in the blood drawing experience. By standardizing the vast part of the procedure, the device reduces dependency on personnel and increases standardization and quality of the blood drawing procedure.
Autonomous Blood Drawing Technology - Vitestro
Autonomous Blood Drawing Technology | Medical Robot

Northwestern Medicine and Vitestro Collaborate to Advance Autonomous Robotic Phlebotomy

Northwestern Medicine and Vitestro announce a multi-year collaboration to advance autonomous robotic phlebotomy in the U.S.

Vitestro Unveils Aletta®: The World’s First Autonomous Robotic Phlebotomy Device™ (ARPD™)

Vitestro, a pioneer in medical robotics, proudly reveals the name of its autonomous blood drawing device: Aletta™, the first autonomous robotic device designed to perform automated blood draws with unparalleled precision and consistency.

Vitestro Appoints Bob Gerberich as Chief Commercial Officer for North America

We are happy to announce the appointment of Bob Gerberich as Chief Commercial Officer for North America. In this role, Bob will lead the U.S. pre-launch market development, commercial strategy, and execution, driving the adoption of Vitestro’s groundbreaking technology across the U.S. healthcare market.

Vitestro Welcomes Two New Board Members

Vitestro is proud to announce the appointment of two new independent board members to its Board of Directors: Dave Hickey and Sjaak Deckers. Both are seasoned leaders in the MedTech industry, bringing decades of experience in scaling high-tech companies, driving innovation, and guiding businesses through critical phases. They have joined Vitestro's board alongside other industry leaders including Dr. Fred Moll, co-founder of Intuitive Surgical and Auris Health.

Vitestro Achieves CE Marking for Autonomous Blood Drawing Device

Vitestro achieves CE marking for their autonomous blood drawing device, acknowledging that the device meets the requirements of the European Medical Device Regulation (MDR) and is now approved for commercial use across the European Union.

Pivotal Trial Study Of Breakthrough Autonomous Blood Draw Technology Confirms Performance, Safety and Patient Acceptance

All performance and safety endpoints were met in A.D.O.P.T. Pivotal Trial Study Phase; other key findings include 95% first-stick success and 98% patient acceptance

Danish hospital pre-orders 3 blood drawing devices, in first international deployment for Vitestro.

In first international deployment for Vitestro, Danish hospital pre-orders 3 blood drawing devices.

Vitestro Secures $22 Million (€20 million) for Autonomous Blood Draw Device

Vitestro raises $22m (€20m) in funding to accelerate commercialization of autonomous blood drawing device globally.

Vitestro haalt €20 miljoen ($22 miljoen) op voor autonoom bloedafnameapparaat

Vitestro, de eerste onderneming die volledig autonome bloedafnameapparaten ontwikkelt, maakt bekend dat het €20 miljoen ($22 miljoen) heeft opgehaald

Maxine Moor joins Vitestro as VP Marketing, Sales and Customer Success for Europe

Maxine Moor joins Vitestro. As the VP of Marketing, Sales, and Customer Success for Europe at Vitestro, Maxine will be responsible for driving the company's commercial strategy and expanding its market presence.

Result Laboratorium zet in op de toekomst en bestelt twee Vitestro bloedafnameapparaten

De order van Result Laboratorium onderstreept de groeiende vraag naar de innovatieve oplossingen van Vitestro in de gezondheidszorg. Vitestro, de toonaangevende innovator op het gebied van bloedafnametechnologie, is verheugd deze belangrijke order van Result Laboratorium, een bekend laboratorium gevestigd in Zevenbergen, Nederland aan te kondigen.

Vitestro secures order from Result Laboratorium for two blood drawing devices – Underscoring growing demand

Vitestro, a leading innovator in blood drawing technology, is pleased to announce a significant order from Result Laboratorium, a renowned laboratory based in Zevenbergen, Netherlands. The order from Result Laboratorium underscores the growing demand for Vitestro's innovative solutions in the healthcare industry

Dutch leading St. Antonius Hospital to deploy two Vitestro blood drawing devices

St. Antonius Hospital signs for two blood drawing devices that could help ease workload and provide a more consistent patient experience.

St. Antonius Ziekenhuis gaat twee bloedafname-apparaten van Vitestro inzetten

Het St. Antonius Ziekenhuis in Nieuwegein en Utrecht gaat twee zelfstandig werkende bloedafnameapparaten van de Utrechtse medische robotica-ontwikkelaar Vitestro inzetten in de dagelijkse praktijk.

Vitestro starts largest-scale clinical trial worldwide for autonomous blood drawing device with enrollment of first patients in A.D.O.P.T.

Vitestro, an expert in medical robotics, has enrolled the first 350 patients in their A.D.O.P.T. Trial (Autonomous Blood Drawing Optimization and Performance Testing) at study site Result Laboratorium - Albert Schweitzer Hospital. Vitestro expects to obtain CE marking by the end of 2024.

Vitestro shows its device at WorldLab in Rome with its first international booth

Vitestro garnered a lot of interest by showing the autonomous blood drawing device, at its first international booth. With an accompanying patient journey video, visitors were able to experience what the future of blood drawing holds.

Amsterdam-based OLVG Lab adopts Vitestro’s autonomous blood drawing devices

Amsterdam-based OLVG Lab, a leading Dutch clinical laboratory, will be the first European healthcare provider to introduce multiple autonomous blood drawing devices manufactured by Utrecht-based developer Vitestro. Both parties have signed an agreement for the acquisition of the devices, which will be installed once CE marking has been obtained. The innovation will contribute to safe, consistent blood drawing, as well as helping to solve the growing healthcare workforce shortage.

OLVG Lab kiest voor bloedafname- apparaten van Vitestro

OLVG Lab gaat als eerste Europese instelling meerdere autonome bloedafnameapparaten van de Utrechtse ontwikkelaar Vitestro in gebruik nemen. Beide partijen hebben daartoe een contract ondertekend. De apparaten zullen worden geplaatst na het behalen van de CE-markering en dragen bij aan een veilige, consistente bloedafname, maar ook aan het oplossen van het toenemende tekort aan personeel in de zorg.

Vitestro receives European Innovation Council Accelerator Grant

Vitestro has been selected for a European Innovation Council (EIC) grant. The EIC grant is a competitive grant and the Vitestro team is grateful to receive it.

Vitestro raises EUR 12 million in Series A financing round to bring the world's first autonomous blood drawing device to the European market

Vitestro, developer of an autonomous blood drawing device, announces the completion of a Series A financing round. California-based Sonder Capital led the funding round alongside existing investors.

Vitestro haalt 12 miljoen euro op richting marktintroductie van 's werelds eerste autonome bloedafnameapparaat

Vitestro, ontwikkelaar van een autonoom bloedafnameapparaat, heeft een Serie A-financieringsronde afgerond. Het in Californië gevestigde Sonder Capital leidde de ronde.

Vitestro unveils autonomous blood drawing device, combining artificial intelligence, ultrasound imaging and robotics

Intuitive to use device, empowering patients to be self-efficacious in the full blood collection procedure

Vitestro receives grant from React-EU

Vitestro is proud to have received a grant from REACT-EU, provided by the European Regional Development Fund (EFRD). The REACT-EU programme (Recovery Assistance for Cohesion and the Territories of Europe).

Vitestro onthult geautomatiseerd bloedafnameapparaat dat kunstmatige intelligentie, echografie en robotica combineert

Eenvoudig te bedienen apparaat waarmee patiënten hun bloedafname volledig zelfstandig kunnen uitvoeren

Wessel van Dijk has joined Vitestro

Bringing expertise, experience and passion for customers and patient care from 30 years of successfully growing MedTech organizations.

Journalists and other media professionals

Do you have any questions,
would you like an interview or
additional information?

Please contact.
Hannah Oevermans,
Marketing & Communication manager,
publicrelations@vitestro.com
VIEW ALL

Founding Story

Autonomous Blood Drawing Technology | Medical Robot | Vitestro
The idea for Vitestro was conceived when Toon and Brian, entrepreneurs and business partners for many years, were discussing frustrations about the availability of care for their loved ones. In Toon's case, a friend's father was very difficult to puncture due to chemotherapy, while Brian's experienced long waiting times and logistic errors when one of his kids needed regular blood checkups.

These personal experiences led to discussions about the cornerstone of good patient care: blood analysis. Together the founders saw an opportunity to improve patient care with intelligent software solutions and autonomous phlebotomy. They decided to start on an adventure together…

Teaming with experts

A few years later, Vitestro’s multi-disciplinary team, with the help of laboratories, hospitals and many other partners is well on their way to transforming patient care globally with the introduction of these innovations.  Do you also thrive on great challenges? Check out our careers page.
WORK AT VITESTRO

TEAM

Our leadership team

Toon Overbeeke
CEO
Co-founder
READ MORE
Brian Joseph
Commercial
Co-founder
READ MORE
Maxine Moor
Commercial Europe
READ MORE
Bob Gerberich
Commercial US
READ MORE
Andy McGibbon
Strategy US
READ MORE
Bert Wiggers
Technical
READ MORE
Dewi Hamwijk
People & Culture
READ MORE
Jasmine Beukema
Quality & Regulatory
READ MORE
Jim Lelivelt
Financial
READ MORE
Luuk Giesen
Medical
READ MORE
Fred Moll
Non-executive board member
READ MORE
Sjaak Deckers
Non-executive board member
READ MORE
Jeroen Hegge
Non-executive board member
READ MORE
Dave Hickey
Non-executive board member
READ MORE

Contact

ADDRESS
Europalaan 500 1.N.2, Utrecht
PHONE NUMBER
+31 30 2004551
Autonomous Blood Drawing Technology | Medical Robot
LINKEDIN
Follow us
Information is shown about a product that may or may not be available in different countries and may or may not have received approval or market clearance by a government regulatory body. Please contact us at hello@vitestro.com to obtain the appropriate product information for your country of residence.
Copyright © 2024 Vitestro
crossmenu